Health Condition 1: null- Preterm Labor
Conditions
Interventions
None listed
Sponsors
Abbott India Limited
Eligibility
Inclusion criteria
Inclusion criteria: Adult women with spontaneous preterm labor (between 24 and 37 weeks of gestation) as diagnosed by the physician and admitted/treated at the study centre in between 1st Jan 2014 to 31st Dec 2016
Exclusion criteria
Exclusion criteria: Women with known short cervix maintained on tocolytics 2. Women with preterm premature rupture of membranes, triplet and higher-order multifetal pregnancy and those with a fetal structural or genetic anomaly 3. Patients with incomplete hospital records (missing notes, reports or any other important data required for the study)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To determine the clinical and obstetric characteristics of patients with preterm labor 2.To determine the pharmacological treatments used in the management of preterm laborTimepoint: At the end of study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To determine the success of different pharmacological treatments in terms of maternal outcomes (tocolysis and prolongation of pregnancy) and neonatal outcomes 2.To determine the latency period with different pharmacological treatments 3. To assess side effects of different pharmacological treatmentsTimepoint: At the end of study | — |
Countries
India
Contacts
Public ContactDr Shubhangi Desai
Abbott India Limited
Outcome results
None listed